Bernoulli was presented with the Patient Safety Sponsorship Award at the AAMI Annual Conference Awards Ceremony in Tampa, FL.

From L-R: Mary Logan, President AAMI; Marilyn Flack, Exec Director, AAMI Foundation;
John Zaleski, Executive Vice President and CIO, Bernoulli; and Phil Cogdill, Chair, AAMI Foundation Board of Directors.

“Bernoulli’s level of partnership and involvement in working with the foundation and its stakeholders demonstrates its commitment to improving patient safety,” said Marilyn Flack, Executive Director of the AAMI Foundation. “I am very grateful to the Bernoulli team for their help in working to prevent patients on opioids from experiencing poor outcomes due to undetected opioid-induced respiratory depression and for their help in working to reduce non-actionable clinical alarms.”

Bernoulli is a premiere partner with the AAMI Foundation and works closely with the foundation and its stakeholders on two important patient safety initiatives: National Coalition for Alarm Management Safety; and the National Coalition to Promote Continuous Monitoring of Patients on Opioids.

Alarm management and continuous monitoring for patients on opioids are two of the top patient safety priorities in healthcare today. Bernoulli supports hospitals and health systems in their efforts to achieve full compliance with the Joint Commission’s National Patient Safety Goal on clinical alarm safety and also enables continuous, real-time surveillance of patients connected to virtually any medical device.